Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Foie
»
Néoplasie
01. Août 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 3852
Articles 1 - 20 / 77039
Management of Primary Hepatic Angiosarcoma: A Comprehensive Review.
J Gastrointest Cancer
Murshid M, Nawawi A.
PMID: 42536112 [PubMed - indexed for MEDLINE]
Machine learning-driven evaluation of protein kinase D3 as a co-diagnostic biomarker in hepatocellular carcinoma.
J Zhejiang Univ Sci B
Li J, Zhao Y, Ma Y, Xie B, Huang L, Yang H, Ma X, Deng H, Wang S, Sun C, Cao P, Li L.
PMID: 42529886 [PubMed - indexed for MEDLINE]
Efficacy of first-line treatment in driver gene-negative non-small cell lung cancer with liver metastases: a Bayesian network meta-analysis.
Front Immunol
Wu W, Guo X, Dong X, Liang H, Zhang L.
PMID: 42529281 [PubMed - indexed for MEDLINE]
Hepatocellular Carcinoma Presenting With Extensive Portal Vein Tumour Thrombus Without Evidence of Underlying Liver Cirrhosis or Steatosis: A Case Report.
Br J Hosp Med (Lond)
Schattner A, Uliel L, Schechtman I, Dubin I.
PMID: 42528428 [PubMed - indexed for MEDLINE]
A Rare Case of Squamous Cell Carcinoma of the Colon.
S D Med
Roberts M, Blankespoor T, Tahir H, Waheed RI, Ahmed M.
PMID: 42527365 [PubMed - indexed for MEDLINE]
Minimally Invasive Versus Open Liver Resection for HCC in the Posterosuperior Segments: A Propensity Score-matched Study.
Anticancer Res
Sakai H, Goto Y, Fukutomi S, Arai S, Midorikawa R, Miyazaki D, Tsuru H, Akashi M, Ishibashi N, Fujita F, Hisaka T.
PMID: 42527069 [PubMed - indexed for MEDLINE]
Abstract: Impact of Chronic Hepatitis C Infection on Inpatient Outcomes and Complications Among Patients With Hepatocellular Carcinoma: A National Inpatient Sample Analysis (2020-2022).
S D Med
Tahir H, Waheed RI, Anwer MZ, Kazim F, Ahmed M.
PMID: 42526003 [PubMed - indexed for MEDLINE]
Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review.
Front Immunol
Tang P, Liu W, Xu Y, Long Y, Li Y, Li J, Liao M, Wang X, Zhou J, Zeng Y.
PMID: 42523995 [PubMed - indexed for MEDLINE]
Evaluating the effectiveness and safety of adjuvant transcatheter arterial chemoembolisation (TACE) after curative resection for Barcelona Clinic Liver Cancer (BCLC) stage 0-B hepatocellular carcinoma: protocol for a target trial emulation study.
BMJ Open
Li Z, Mi S, Li X, Ren Q.
PMID: 42521316 [PubMed - indexed for MEDLINE]
Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma.
PLoS One
Gu K, Kang TW, Shin J, Sinn DH, Goh MJ, Hong JY, Chi S.
PMID: 42520023 [PubMed - indexed for MEDLINE]
Neoadjuvant therapy for hepatocellular carcinoma: emerging combinations and biomarker challenges.
Front Immunol
Palihati S, Mo H, Ye X, Yi C, Liang X.
PMID: 42519345 [PubMed - indexed for MEDLINE]
Economic value of finotonlimab plus bevacizumab versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma in China and the United States.
Front Public Health
He Y, Jiang Q, Pan X, Deng L, Hu X, Yang Z, Lang W.
PMID: 42518569 [PubMed - indexed for MEDLINE]
Effects of Sevoflurane on the Proliferation, Migration, and Xenograft Growth of HepG2 Hepatocellular Carcinoma Cells: An Exploratory In Vitro and In Vivo Study.
Medicina (Kaunas)
Kim KS, Kim Y, Shin K, Paing AS, Baek S, Hong B, Lim C.
PMID: 42512809 [PubMed - indexed for MEDLINE]
Clinical and Genetic Determinants of Hepatocellular Carcinoma in a Turkish Cohort: Impact of SLCO1B1 and SLCO1B3 Germline Variations and Demographic Risk Factors.
Int J Mol Sci
Altintas Z.
PMID: 42511559 [PubMed - indexed for MEDLINE]
Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation.
Int J Mol Sci
Mu X, Meng W, Zheng L.
PMID: 42511550 [PubMed - indexed for MEDLINE]
Genome-Wide Association Studies in Hepatocellular Carcinoma: Aetiology-Specific Susceptibility, Functional Interpretation, and Clinical Translation.
Genes (Basel)
Zhang S, Long X.
PMID: 42510799 [PubMed - indexed for MEDLINE]
Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options.
Curr Oncol
Kang NK, Lee SJ, Kang HJ, Shin HJ, Kwon JH, Lee SK, Kim M.
PMID: 42505227 [PubMed - indexed for MEDLINE]
Where does histotripsy fit into hepatocellular carcinoma care?
Cancer
Lau-Min KS, Wang J.
PMID: 42504148 [PubMed - indexed for MEDLINE]
[Primary hepatic actinomycosis mimicking a malignant liver tumor: Case report and review of the Latin American literature].
Rev Gastroenterol Peru
Cubas-Garcia D, Sanchez-Zavaleta J, Román-Hernández G, Kapsoli-Sanchez MDC, Urbina-Rojas N.
PMID: 42501997 [PubMed - indexed for MEDLINE]
Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence-Free Survival in HCC.
Liver Int
Liu R, Xie Y, Yue L, Jia J, Wang L, Liao J, Li HW, Yao H, Zhang J, Wang Y, Zhou X, Shi W, Ma J, Chen Q, Ma X, Zhou W, Yang L, Ning G, Zhou Y, Hu P, Li F, Zhuo L.
PMID: 42500825 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 77039
Page 1 de 3852
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité